In their June 4, 2020 Newsletter, the Institute for Safe Medication Practices (ISMP) announces vials of vecuronium bromide and rocuronium bromide will temporarily not carry the warning statement atop the vial caps. The COVID-19 demand for paralyzing agents in intensive care units and supply chain disruptions have contributed to shortage of these safety caps with embossed labeling. For more information, please visit the ISMP Newsletter below.
- ISMP June 4th, 2020 Newsletter: https://www.ismp.org/acute-care/medication-safety-alert-june-4-2020
- FDA announcement on temporary absence of safety warning cap on paralyzing agent vials: https://www.fda.gov/drugs/drug-safety-and-availability/fda-alerts-health-care-professionals-temporary-absence-warning-statement-vial-caps-two-neuromuscular